These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9236918)
1. A sensitive enzyme immunoassay of human thyroid-stimulating hormone (TSH) using bispecific F(ab')2 fragments recognizing polymerized alkaline phosphatase and TSH. Morimoto K; Inouye K J Immunol Methods; 1997 Jun; 205(1):81-90. PubMed ID: 9236918 [TBL] [Abstract][Full Text] [Related]
2. Bispecific-Ab-based immunoassay of thyroid-stimulating hormone. Inouye K Cancer Immunol Immunother; 1997; 45(3-4):159-61. PubMed ID: 9435863 [TBL] [Abstract][Full Text] [Related]
3. Method for the preparation of bispecific F(ab')2mu fragments from mouse monoclonal antibodies of the immunoglobulin M class and characterization of the fragments. Morimoto K; Inouye K J Immunol Methods; 1999 Apr; 224(1-2):43-50. PubMed ID: 10357205 [TBL] [Abstract][Full Text] [Related]
4. Use of high-capacity surface with oriented recombinant antibody fragments in a 5-min immunoassay for thyroid-stimulating hormone. Brockmann EC; Vehniäinen M; Pettersson K Anal Biochem; 2010 Jan; 396(2):242-9. PubMed ID: 19818328 [TBL] [Abstract][Full Text] [Related]
5. Studies of possible antiidiotypic control mechanisms in Graves' disease. Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588 [TBL] [Abstract][Full Text] [Related]
6. Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA). Robert B; Dorvillius M; Buchegger F; Garambois V; Mani JC; Pugnières M; Mach JP; Pèlegrin A Int J Cancer; 1999 Apr; 81(2):285-91. PubMed ID: 10188732 [TBL] [Abstract][Full Text] [Related]
7. Bispecific rabbit Fab'-bovine serum albumin conjugate used in hemagglutination immunoassay for beta-microseminoprotein. Yukawa N; Osawa M; Saito T; Hasegawa T; Matsuda H; Takahama K; Takeichi S J Immunoassay; 1997 Aug; 18(3):215-33. PubMed ID: 9257262 [TBL] [Abstract][Full Text] [Related]
8. Bispecific F (ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells. Nitta T; Yagita H; Azuma T; Sato K; Okumura K Eur J Immunol; 1989 Aug; 19(8):1437-41. PubMed ID: 2528460 [TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo. Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311 [TBL] [Abstract][Full Text] [Related]
10. [Bi-specific F(ab')2 enhances cytolytic activities of LAK cells against human small cell lung cancer (SCLC)]. Azuma A; Niitani H Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1132-7. PubMed ID: 1661346 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody. Negri DR; Tosi E; Valota O; Ferrini S; Cambiaggi A; Sforzini S; Silvani A; Ruffini PA; Colnaghi MI; Canevari S Br J Cancer; 1995 Oct; 72(4):928-33. PubMed ID: 7547242 [TBL] [Abstract][Full Text] [Related]
13. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Woodle ES; Thistlethwaite JR; Ghobrial IA; Jolliffe LK; Stuart FP; Bluestone JA Transplantation; 1991 Aug; 52(2):354-60. PubMed ID: 1908148 [TBL] [Abstract][Full Text] [Related]
14. Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity. van Dijk J; Zegveld ST; Fleuren GJ; Warnaar SO Int J Cancer; 1991 Jul; 48(5):738-43. PubMed ID: 1830033 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies. Welfringer F; d'Athis P; Scherrmann JM; Hervé F J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to placental alkaline phosphatase: preclinical evaluation in a human xenograft tumour model of F(ab')2 and Fab fragments. Durbin H; Milligan EM; Mather SJ; Tucker DF; Raymond R; Bodmer WF Int J Cancer Suppl; 1988; 2():59-66. PubMed ID: 3162446 [TBL] [Abstract][Full Text] [Related]
17. Development of a sensitive, rapid, biotin-streptavidin based chemiluminescent enzyme immunoassay for human thyroid stimulating hormone. Lin Z; Wang X; Li ZJ; Ren SQ; Chen GN; Ying XT; Lin JM Talanta; 2008 May; 75(4):965-72. PubMed ID: 18585170 [TBL] [Abstract][Full Text] [Related]
18. Different behaviour of mouse-human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub-class in vivo. Buchegger F; Pèlegrin A; Hardman N; Heusser C; Lukas J; Dolci W; Mach JP Int J Cancer; 1992 Feb; 50(3):416-22. PubMed ID: 1735611 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer. Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596 [TBL] [Abstract][Full Text] [Related]
20. Effect of unlabelled monoclonal antibodies on the biodistribution of 111In-labelled anti-prostate-specific acid phosphatase monoclonal antibodies in the mouse model. Peräalä-Heape M; Vihko P; Vihko R Anticancer Res; 1991; 11(3):1327-31. PubMed ID: 1888168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]